Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Internal Medicine (Tokyo, Japan)|May 17, 2013
Systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies against bactericidal/permeability increasing proteinAtsuro Fukuhara, Yoshinori Tanino, Suguru Sato, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 8, 2017
The clinical role of fractional exhaled nitric oxide in asthma controlSuguru Sato, Junpei Saito, Atsuro Fukuhara, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 21, 2012
Association of asthma education with asthma control evaluated by asthma control test, FEV1, and fractional exhaled nitric oxideJunpei Saito, Suguru Sato, Atsuro Fukuhara, et al.Inflammation|August 14, 2014
Secretoglobin 3A2 attenuates lipopolysaccharide-induced inflammation through inhibition of ERK and JNK pathways in bronchial epithelial cellsXintao Wang, Yoshinori Tanino, Suguru Sato, et al.Respiratory Investigation|February 17, 2016
Cholesteryl palmitate crystals in bronchoalveolar lavage fluid smears as a possible prognostic biomarker for chronic interstitial pneumonia: A preliminary studyNaoko Fukuhara, Motoko Tachihara, Yoshinori Tanino, et al.Respiratory Research|May 6, 2018
A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial PneumoniaJannie M B Sand, Yoshinori Tanino, Morten A Karsdal, et al.Allergology International : Official Journal of the Japanese Society of Allergology|March 30, 2016
Exhaled nitric oxide and inducible nitric oxide synthase gene polymorphism in Japanese asthmaticsSuguru Sato, Xintao Wang, Junpei Saito, et al.Respiratory Investigation|May 23, 2024
Simple prediction tools for disease progression in unvaccinated patients with mild/moderate COVID-19 aged under 65 years: Simplified DOATS and DOAT scoresYoko Shibata, Hiroyuki Minemura, Yasuhito Suzuki, et al.International Journal of Molecular Sciences|October 12, 2019
Syndecan-4 Inhibits the Development of Pulmonary Fibrosis by Attenuating TGF-β SignalingYoshinori Tanino, Xintao Wang, Takefumi Nikaido, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Validation study of asthma screening criteria based on subjective symptoms and fractional exhaled nitric oxideAtsuro Fukuhara, Junpei Saito, Suguru Sato, et al.Pageof 5